"Substantial Improvement" Standard, 50% Cap Remain In Inpatient PPS Rule

Manufacturers will be allowed to appeal to a CMS advisory panel for reconsideration of whether a new technology qualifies as a "substantial improvement" in the diagnosis and treatment of Medicare beneficiaries, according to the agency's inpatient prospective payment system (PPS) final rule.